1. Home
  2. DCBO vs ACHV Comparison

DCBO vs ACHV Comparison

Compare DCBO & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

N/A

Current Price

$23.18

Market Cap

584.3M

Sector

N/A

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.50

Market Cap

618.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DCBO
ACHV
Founded
2016
N/A
Country
Canada
United States
Employees
900
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
584.3M
618.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
DCBO
ACHV
Price
$23.18
$7.50
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$32.00
$14.67
AVG Volume (30 Days)
103.0K
1.1M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.89
N/A
Revenue Next Year
$11.44
N/A
P/E Ratio
$22.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$2.55
52 Week High
$32.20
$7.34

Technical Indicators

Market Signals
Indicator
DCBO
ACHV
Relative Strength Index (RSI) 63.72 73.79
Support Level $16.54 $4.04
Resistance Level $26.48 N/A
Average True Range (ATR) 1.07 0.33
MACD 0.19 0.08
Stochastic Oscillator 82.03 98.71

Price Performance

Historical Comparison
DCBO
ACHV

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: